New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!

EXEL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.85%

Insider Buying (Last 12 Months): $15,270,038.49

Insider Selling (Last 12 Months): $21,654,310.33

Exelixis Insider Trading History Chart

Exelixis Share Price & Price History

^$34.65

▲ +0.24 (0.70%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

Download Our Tesla Ebook For Free

From DTI | Ad

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.

Exelixis Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/18/2024	Patrick J Haley	EVP	Sell	41,588	$34.36	$1,428,963.68	288,665
11/5/2024	Dana Aftab	EVP	Sell	96,986	$35.00	$3,394,510.00	498,945
11/1/2024	George Poste	Director	Sell	30,000	$34.00	$1,020,000.00	169,020
11/1/2024	Jeffrey J. Hessekiel	EVP	Sell	50,000	$34.13	$1,706,500.00	530,325
10/30/2024	Dana Aftab	EVP	Sell	1,162	$31.40	$36,486.80	498,945
10/28/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$28.39	$709,750.00	580,325
9/23/2024	Jeffrey J. Hessekiel	EVP	Sell	25,000	$26.38	$659,500.00	605,325
8/26/2024	Jeffrey J. Hessekiel	EVP	Sell	20,000	$25.79	$515,800.00	630,325
8/14/2024	Maria C. Freire	Director	Sell	8,250	$26.56	$219,120.00	91,007
8/12/2024	Dana Aftab	EVP	Sell	20,883	$27.06	$565,093.98	500,107
8/9/2024	Christopher J Senner	CFO	Sell	125,000	$27.19	$3,398,750.00	721,680
8/8/2024	George Poste	Director	Sell	33,725	$26.89	$906,865.25	199,020
8/7/2024	Dana Aftab	EVP	Sell	95,000	$25.00	$2,375,000.00	520,990
6/4/2024	Jack L Wyszomierski	Director	Sell	8,287	$22.00	$182,314.00	349,499
5/30/2024	David Edward Johnson	Director	Buy	225,000	$20.76	$4,671,000.00	1,525,730
5/28/2024	David Edward Johnson	Director	Buy	200,000	$20.32	$4,064,000.00	1,300,730
5/21/2024	George Poste	Director	Sell	11,686	$20.96	$244,938.56	213,907
5/13/2024	Jack L Wyszomierski	Director	Sell	10,923	$21.37	$233,424.51	338,948
3/21/2024	Alan M. Garber	Director	Sell	19,205	$24.01	$461,112.05	35,703
2/23/2024	Patrick J Haley	EVP	Sell	47,020	$21.45	$1,008,579.00	384,866
2/21/2024	David Edward Johnson	Director	Buy	190,000	$20.70	$3,933,000.00	1,100,730
12/14/2023	Patrick J Haley	EVP	Sell	50,000	$23.35	$1,167,500.00	307,687
12/12/2023	Patrick J Haley	EVP	Sell	14,149	$22.50	$318,352.50	307,687
12/4/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.06	$551,500.00	558,345
11/30/2023	Jeffrey J. Hessekiel	EVP	Sell	25,000	$22.01	$550,250.00	583,345
11/27/2023	David Edward Johnson	Director	Buy	120,409	$21.61	$2,602,038.49	910,730
8/30/2023	Dana Aftab	EVP	Sell	4,600	$22.47	$103,362.00	399,943
8/3/2023	Christopher J Senner	CFO	Sell	60,000	$20.51	$1,230,600.00	571,631
8/3/2023	Patrick J Haley	EVP	Sell	30,553	$20.67	$631,530.51	285,467
8/1/2023	Jeffrey J. Hessekiel	EVP	Sell	55,710	$19.63	$1,093,587.30	571,976
4/5/2023	Jeffrey J. Hessekiel	EVP	Sell	38,930	$20.01	$778,989.30	582,435
3/10/2023	Jack L Wyszomierski	Director	Sell	15,300	$16.61	$254,133.00	317,467
3/1/2023	Jeffrey J. Hessekiel	EVP	Sell	77,860	$17.13	$1,333,741.80	527,716
2/27/2023	Dana Aftab	EVP	Sell	10	$17.50	$175.00	351,472
2/21/2023	Alan M. Garber	Director	Sell	40,000	$17.49	$699,600.00	31,417
2/9/2023	Carl B. Feldbaum	Director	Sell	40,000	$17.78	$711,200.00	18,701
2/6/2023	Patrick J Haley	EVP	Sell	25,000	$17.37	$434,250.00	254,414
12/15/2022	Peter Lamb	EVP	Sell	20,000	$15.88	$317,600.00	410,958
11/29/2022	George Poste	Director	Sell	40,000	$16.68	$667,200.00	193,189
9/12/2022	Patrick J Haley	EVP	Sell	40,000	$17.94	$717,600.00	261,591
5/27/2022	Patrick J Haley	EVP	Sell	18,812	$18.21	$342,566.52	239,818
5/17/2022	Jeffrey J. Hessekiel	EVP	Sell	18,000	$25.39	$457,020.00	604,822
5/12/2022	Lance Willsey	Director	Sell	40,000	$19.65	$786,000.00	424,415
4/4/2022	Jack L Wyszomierski	Director	Sell	6,696	$23.00	$154,008.00	273,192
3/31/2022	Patrick J Haley	EVP	Sell	10,000	$22.43	$224,300.00	269,191
3/28/2022	Jeffrey J. Hessekiel	EVP	Sell	4,717	$22.00	$103,774.00
3/1/2022	Alan M. Garber	Director	Sell	21,301	$21.00	$447,321.00
2/24/2022	Jeffrey J. Hessekiel	EVP	Sell	18,000	$20.00	$360,000.00
2/22/2022	Stelios Papadopoulos	Director	Sell	84,515	$19.56	$1,653,113.40
2/3/2022	Patrick J Haley	EVP	Sell	60,000	$17.91	$1,074,600.00
12/15/2021	Peter Lamb	EVP	Sell	47,500	$17.44	$828,400.00
11/24/2021	Patrick J Haley	EVP	Sell	17,236	$17.25	$297,321.00
11/19/2021	Carl B. Feldbaum	Director	Sell	20,000	$17.62	$352,400.00

Trump won. Buy this coin now.

From Weiss Ratings | Ad

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

This could be his favorite coin.

SEC Filings (Institutional Ownership Changes) for Exelixis (NASDAQ:EXEL)

85.27% of Exelixis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exelixis Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/18/2024	TD Private Client Wealth LLC	9,756	$0.25M	0.0%	+376.8%	0.003%
11/18/2024	Teachers Retirement System of The State of Kentucky	102,776	$2.67M	0.0%	-2.4%	0.036%
11/18/2024	Neo Ivy Capital Management	10,210	$0.26M	0.1%	N/A	0.004%
11/18/2024	Coldstream Capital Management Inc.	9,113	$0.24M	0.0%	N/A	0.003%
11/16/2024	Geode Capital Management LLC	5,162,924	$134.01M	0.0%	-0.1%	1.808%
11/15/2024	Vestcor Inc	59,789	$1.55M	0.0%	+1.2%	0.021%
11/15/2024	M&T Bank Corp	14,433	$0.37M	0.0%	+12.7%	0.005%
11/15/2024	Barclays PLC	319,589	$8.29M	0.0%	-24.3%	0.112%
11/15/2024	Peloton Wealth Strategists	46,630	$1.21M	0.5%	-2.5%	0.016%
11/15/2024	Public Employees Retirement System of Ohio	113,752	$2.95M	0.0%	-32.4%	0.040%
11/15/2024	Y Intercept Hong Kong Ltd	13,393	$0.35M	0.0%	-74.4%	0.005%
11/15/2024	MML Investors Services LLC	22,958	$0.60M	0.0%	+9.9%	0.008%
11/15/2024	EP Wealth Advisors LLC	11,804	$0.31M	0.0%	N/A	0.004%
11/15/2024	United Services Automobile Association	18,500	$0.48M	0.0%	-21.2%	0.006%
11/15/2024	Krensavage Asset Management LLC	1,281,612	$33.26M	18.6%	-23.6%	0.449%
11/15/2024	Kovitz Investment Group Partners LLC	17,739	$0.42M	0.0%	N/A	0.006%
11/15/2024	Wellington Management Group LLP	245,342	$6.37M	0.0%	-33.7%	0.086%
11/15/2024	Two Sigma Advisers LP	1,702,590	$44.18M	0.1%	+6.1%	0.596%
11/15/2024	State Street Corp	11,443,668	$296.96M	0.0%	-9.2%	4.007%
11/15/2024	Systematic Financial Management LP	1,168,391	$30.32M	0.8%	+7.1%	0.409%
11/15/2024	Point72 DIFC Ltd	17,200	$0.45M	0.0%	N/A	0.006%
11/15/2024	NFJ Investment Group LLC	61,012	$1.58M	0.0%	N/A	0.021%
11/15/2024	Jacobs Levy Equity Management Inc.	2,082,283	$54.04M	0.2%	-17.4%	0.729%
11/15/2024	Janus Henderson Group PLC	123,347	$3.20M	0.0%	+1.0%	0.043%
11/15/2024	HighTower Advisors LLC	64,728	$1.68M	0.0%	-3.0%	0.023%
11/15/2024	Centiva Capital LP	14,641	$0.38M	0.0%	-6.3%	0.005%
11/15/2024	Paloma Partners Management Co	18,635	$0.48M	0.0%	N/A	0.007%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	25,308	$0.66M	0.1%	N/A	0.009%
11/15/2024	Point72 Hong Kong Ltd	36,918	$0.96M	0.1%	N/A	0.013%
11/15/2024	Erste Asset Management GmbH	74,500	$1.93M	0.0%	N/A	0.026%
11/14/2024	Bellevue Group AG	1,600,000	$41.52M	0.7%	-11.3%	0.560%
11/14/2024	Edgestream Partners L.P.	73,208	$1.90M	0.1%	-36.2%	0.026%
11/14/2024	Caisse DE Depot ET Placement DU Quebec	577,228	$14.98M	0.0%	N/A	0.202%
11/14/2024	Verition Fund Management LLC	47,195	$1.23M	0.0%	N/A	0.017%
11/14/2024	Captrust Financial Advisors	35,430	$0.92M	0.0%	+4.0%	0.012%
11/14/2024	Capstone Investment Advisors LLC	24,070	$0.63M	0.0%	N/A	0.008%
11/14/2024	Vinva Investment Management Ltd	23,587	$0.61M	0.0%	-2.1%	0.008%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	810,541	$21.03M	0.0%	-6.4%	0.284%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	60,098	$1.56M	0.0%	-2.4%	0.021%
11/14/2024	MetLife Investment Management LLC	158,315	$4.11M	0.0%	-3.7%	0.055%
11/14/2024	CreativeOne Wealth LLC	7,837	$0.20M	0.0%	N/A	0.003%
11/13/2024	BNP Paribas Financial Markets	131,659	$3.42M	0.0%	-19.7%	0.046%
11/13/2024	Brooklyn Investment Group	1,635	$42K	0.0%	N/A	0.001%
11/13/2024	Quantbot Technologies LP	5,748	$0.15M	0.0%	N/A	0.002%
11/13/2024	FMR LLC	2,462,072	$63.89M	0.0%	+6.1%	0.862%
11/13/2024	The Manufacturers Life Insurance Company	241,037	$6.26M	0.0%	-5.0%	0.084%
11/13/2024	Bank of Montreal Can	104,385	$2.71M	0.0%	+51.5%	0.037%
11/13/2024	Hancock Whitney Corp	47,733	$1.24M	0.0%	+11.5%	0.017%
11/13/2024	Dynamic Technology Lab Private Ltd	22,791	$0.59M	0.1%	N/A	0.008%
11/12/2024	Algert Global LLC	276,040	$7.16M	0.2%	-0.1%	0.097%
11/12/2024	Cerity Partners LLC	27,994	$0.73M	0.0%	+129.1%	0.010%
11/12/2024	Charles Schwab Investment Management Inc.	3,273,620	$84.95M	0.0%	-1.0%	1.146%
11/12/2024	Navellier & Associates Inc.	22,070	$0.57M	0.1%	N/A	0.008%
11/12/2024	Massachusetts Financial Services Co. MA	326,254	$8.47M	0.0%	-29.8%	0.114%
11/9/2024	Landscape Capital Management L.L.C.	27,770	$0.72M	0.1%	N/A	0.010%
11/9/2024	Intech Investment Management LLC	232,041	$6.02M	0.1%	+48.2%	0.081%
11/8/2024	Moran Wealth Management LLC	29,946	$0.78M	0.0%	+59.1%	0.010%
11/8/2024	Grandfield & Dodd LLC	12,020	$0.31M	0.0%	N/A	0.004%
11/8/2024	EULAV Asset Management	500,000	$12.98M	0.3%	-8.3%	0.175%
11/8/2024	Ontario Teachers Pension Plan Board	35,823	$0.93M	0.0%	-70.7%	0.013%
11/8/2024	Advisors Asset Management Inc.	19,853	$0.52M	0.0%	+3.2%	0.007%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	75,995	$1.97M	0.0%	N/A	0.027%
11/8/2024	Commerce Bank	188,298	$4.89M	0.0%	-16.9%	0.066%
11/8/2024	Phocas Financial Corp.	144,782	$3.76M	0.0%	-5.9%	0.051%
11/7/2024	Quest Partners LLC	29,833	$0.77M	0.1%	-27.8%	0.010%
11/7/2024	Swiss National Bank	511,700	$13.28M	0.0%	-1.9%	0.179%
11/7/2024	Thrivent Financial for Lutherans	75,684	$1.96M	0.0%	-4.3%	0.027%
11/6/2024	Mutual of America Capital Management LLC	154,166	$4M	0.0%	-7.6%	0.054%
11/6/2024	Seizert Capital Partners LLC	469,940	$12.20M	0.6%	+8.0%	0.165%
11/6/2024	Natixis Advisors LLC	29,113	$0.76M	0.0%	+26.2%	0.010%
11/6/2024	Cornercap Investment Counsel Inc.	24,903	$0.65M	0.2%	-50.7%	0.009%
11/6/2024	CIBC Asset Management Inc	8,758	$0.23M	0.0%	N/A	0.003%
11/6/2024	Sargent Investment Group LLC	232,245	$6.03M	1.1%	-4.4%	0.081%
11/5/2024	Buck Wealth Strategies LLC	8,500	$0.22M	0.1%	N/A	0.003%
11/5/2024	Victory Capital Management Inc.	136,178	$3.53M	0.0%	+16.6%	0.048%
11/5/2024	GSA Capital Partners LLP	11,708	$0.30M	0.0%	-81.9%	0.004%
11/5/2024	Entropy Technologies LP	18,300	$0.48M	0.0%	N/A	0.006%
11/4/2024	Los Angeles Capital Management LLC	1,790,855	$46.47M	0.2%	+124.0%	0.627%
11/4/2024	State of New Jersey Common Pension Fund D	107,585	$2.79M	0.0%	-3.5%	0.038%
11/4/2024	Meritage Portfolio Management	413,586	$10.73M	0.7%	-0.1%	0.145%
11/2/2024	Costello Asset Management INC	1,520	$39K	0.0%	-46.1%	0.001%
11/2/2024	Covestor Ltd	6,335	$0.16M	0.1%	+5.7%	0.002%
11/1/2024	CWA Asset Management Group LLC	22,222	$0.58M	0.0%	N/A	0.008%
11/1/2024	Capital Performance Advisors LLP	2,358	$61K	0.0%	N/A	0.001%
11/1/2024	Summit Global Investments	25,583	$0.66M	0.0%	-24.9%	0.009%
10/31/2024	Principal Financial Group Inc.	665,742	$17.28M	0.0%	-31.6%	0.233%
10/30/2024	Heritage Investors Management Corp	7,728	$0.20M	0.0%	N/A	0.003%
10/30/2024	Capital Management Corp VA	365,270	$9.48M	1.7%	+7.5%	0.128%
10/30/2024	Amalgamated Bank	139,712	$3.63M	0.0%	-6.9%	0.049%
10/30/2024	QRG Capital Management Inc.	54,879	$1.42M	0.0%	+6.4%	0.019%
10/29/2024	Robeco Institutional Asset Management B.V.	483,064	$12.54M	0.0%	+263.1%	0.169%
10/29/2024	Fort L.P.	8,680	$0.23M	0.6%	N/A	0.003%
10/29/2024	Van ECK Associates Corp	173,584	$4.92M	0.0%	+66.2%	0.061%
10/29/2024	Janney Montgomery Scott LLC	30,399	$0.79M	0.0%	-48.3%	0.011%
10/29/2024	Janney Capital Management LLC	13,521	$0.35M	0.0%	-3.9%	0.005%
10/29/2024	Farther Finance Advisors LLC	3,940	$0.10M	0.0%	+467.7%	0.001%
10/28/2024	Stephens Inc. AR	9,689	$0.25M	0.0%	N/A	0.003%
10/28/2024	Stephens Investment Management Group LLC	3,806,564	$98.78M	1.3%	-1.9%	1.334%
10/28/2024	Rice Hall James & Associates LLC	20,766	$0.54M	0.0%	-3.0%	0.007%
10/28/2024	US Bancorp DE	48,110	$1.25M	0.0%	-2.1%	0.017%

Data available starting January 2016

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of progressive and metastatic medullary thyroid cancer. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, RET, and VEGF receptors. The company also offers COTELLIC, an inhibitor of MEK as a combination regimen to treat specific forms of advanced melanoma; and MINNEBRO, an oral non-steroidal selective blocker of the mineralocorticoid receptor for the treatment of hypertension in Japan. It develops zanzalintinib, a novel, potent, next-generation oral tyrosine kinase inhibitor (TKI) that targets VEGF receptors, MET and the TAM kinases (TYRO3, AXL and MER); and XB002, a next-generation tissue factor (TF)-targeting ADC, administered via intravenous infusion and composed of a human monoclonal antibody (mAb) against TF that is conjugated to an auristatin-based microtubulin inhibitor (MTI) payload. It has research collaborations and license agreements with Ipsen Pharma SAS; Takeda Pharmaceutical Company Ltd.; F. Hoffmann-La Roche Ltd.; Redwood Bioscience, Inc.; R.P. Scherer Technologies, LLC; Catalent Pharma Solutions, Inc.; NBE Therapeutics AG; Aurigene Discovery Technologies Limited; Iconic Therapeutics, Inc.; Invenra, Inc.; StemSynergy Therapeutics, Inc.; Genentech, Inc.; Bristol-Myers Squibb Company; and Daiichi Sankyo Company, Limited, as well as clinical development agreement with Sairopa B.V. for ADU-1805. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was incorporated in 1994 and is headquartered in Alameda, California.

Today's Range

Now: $34.65

$34.25

$34.81

50 Day Range

MA: $29.55

$25.39

$36.25

52 Week Range

Now: $34.65

$19.20

$36.60

Volume

1,758,812 shs

Average Volume

2,080,114 shs

Market Capitalization

$9.90 billion

P/E Ratio

22.21

Dividend Yield

N/A

Beta

0.51

Who are the company insiders with the largest holdings of Exelixis?: Exelixis' top insider shareholders include:
David Edward Johnson (Director)
Christopher J Senner (CFO)
Jeffrey Hessekiel (EVP)
Dana Aftab (EVP)
Peter Lamb (EVP)
Patrick J Haley (EVP)
Jack L Wyszomierski (Director)
George Poste (Director)
Maria C Freire (Director)
Alan M Garber (Director)
Carl B Feldbaum (Director)
Learn More about top insider investors at Exelixis.
Who are the major institutional investors of Exelixis?: Exelixis' top institutional investors include:
State Street Corp — 4.01%
Geode Capital Management LLC — 1.81%
Stephens Investment Management Group LLC — 1.33%
Charles Schwab Investment Management Inc. — 1.15%
FMR LLC — 0.86%
Jacobs Levy Equity Management Inc. — 0.73%
Learn More about top institutional investors of Exelixis stock.
Which major investors are selling Exelixis stock?: During the previous quarter, EXEL stock was sold by these institutional investors:
State Street Corp
Assenagon Asset Management S.A.
Jacobs Levy Equity Management Inc.
Krensavage Asset Management LLC
Meditor Group Ltd
Principal Financial Group Inc.
Allspring Global Investments Holdings LLC
abrdn plc
Within the previous year, company insiders that have sold Exelixis company stock include:
David Edward Johnson (Director)
Christopher J Senner (CFO)
Jeffrey Hessekiel (EVP)
Dana Aftab (EVP)
Peter Lamb (EVP)
Patrick J Haley (EVP)
Jack L Wyszomierski (Director)
George Poste (Director)
Learn More investors selling Exelixis stock.
Which major investors are buying Exelixis stock?: In the previous quarter, EXEL stock was acquired by institutional investors including:
Los Angeles Capital Management LLC
Caisse DE Depot ET Placement DU Quebec
Robeco Institutional Asset Management B.V.
Citigroup Inc.
Point72 Asset Management L.P.
FMR LLC
Parallax Volatility Advisers L.P.
Raymond James & Associates